sec filing
NR
NASDAQ · NRXS
NeurAxis, Inc.
Healthcare · Biotechnology
$6.26
Down-$0.02 (-0.32%)
Updated Aug 19, 2026, 12:55 PM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 28.12M
- P/E ratio
- -3.46
- Dividend yield
- 0.00%
- 52-week range
- $2.21 – $9.33
- Volume
- 31.13K
- Avg. volume
- 388.77K
Price performance
NRXS price history
1M range · 21 trading sessions · Daily adjusted prices
NRXS closed at $6.26 after 21 trading sessions, down 10.70% for the selected period.
- Last close
- $6.26
- Period change
- -10.70%
- Period low
- $6.04
- Period high
- $7.09
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $6.24 | $6.44 | $6.2298 | $6.26 | 31.13K |
| Aug 17, 2026 | $6.31 | $6.4605 | $6.17 | $6.28 | 102.83K |
| Aug 14, 2026 | $6.46 | $6.505 | $6.195 | $6.30 | 54.03K |
| Aug 13, 2026 | $6.32 | $6.7813 | $6.27 | $6.28 | 88.88K |
| Aug 12, 2026 | $6.50 | $6.74 | $6.20 | $6.27 | 152.14K |
| Aug 11, 2026 | $6.05 | $6.7823 | $5.50 | $6.35 | 395.15K |
| Aug 10, 2026 | $7.09 | $7.21 | $6.83 | $6.87 | 53.68K |
| Aug 7, 2026 | $6.93 | $7.20 | $6.89 | $7.09 | 44.78K |
| Aug 6, 2026 | $6.85 | $6.94 | $6.79 | $6.93 | 62.9K |
| Aug 5, 2026 | $7.01 | $7.20 | $6.79 | $6.79 | 43.67K |
| Aug 4, 2026 | $6.74 | $7.21 | $6.60 | $7.01 | 159.8K |
| Aug 3, 2026 | $6.33 | $6.745 | $6.33 | $6.59 | 78.71K |
| Jul 31, 2026 | $6.27 | $6.37 | $6.14 | $6.25 | 42.9K |
| Jul 30, 2026 | $6.00 | $6.60 | $6.00 | $6.28 | 165.82K |
| Jul 29, 2026 | $6.43 | $6.5347 | $5.78 | $6.04 | 167.72K |
| Jul 28, 2026 | $6.74 | $6.796 | $6.40 | $6.53 | 90.81K |
| Jul 27, 2026 | $6.82 | $6.87 | $6.57 | $6.74 | 110.77K |
| Jul 24, 2026 | $7.00 | $7.07 | $6.70 | $6.80 | 36.69K |
| Jul 23, 2026 | $6.85 | $7.16 | $6.8486 | $7.01 | 44.02K |
| Jul 22, 2026 | $6.98 | $7.0699 | $6.87 | $6.87 | 23.9K |
| Jul 21, 2026 | $6.91 | $7.27 | $6.81 | $7.01 | 115.38K |
Latest NRXS news
The latest Smart Investors Daily articles mentioning NRXS.
Stock researchCompany · Financials
Loading stock research…